Vismodegib in Treating Patients With Advanced Chondrosarcomas

Clinical trial NCT01267955 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01267955
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Chondrosarcoma Dedifferentiated Chondrosarcoma Locally Advanced Chondrosarcoma Mesenchymal Chondrosarcoma Metastatic Chondrosarcoma Primary Central Chondrosarcoma Unresectable Primary Central Chondrosarcoma

Start date: 2010-12-21
Primary completion: 2018-06-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.